Aptahem AB (XSAT:APTA) Net Income Including Noncontrolling Interests : kr-11.33 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Aptahem AB's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was kr-2.73 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was kr-11.33 Mil.

Aptahem AB Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Aptahem AB's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Net Income Including Noncontrolling Interests Chart

Aptahem AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

-17.50

-24.28

-28.48

-8.87

-11.11

Aptahem AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															-2.52	-2.74	-1.59	-4.27	-2.73

Aptahem AB Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-11.33 Mil.

Aptahem AB Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB (XSAT:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norra Vallgatan 58, Malmo, SWE, 211 22

Website

http://www.aptahem.com

Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB (XSAT:APTA) Headlines

No Headlines